Description: RenovaCare, Inc. is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Our initial products under development target the body's largest organ, the skin. Our flagship technology, the CellMist System, uses our proprietary SkinGun to spray a liquid suspension of a patient's stem cells and the CellMist Solution onto wounds. In investigative clinical use in the United States, SkinGun treatments have shown the potential to naturally and rapidly heal burns and other serious wounds. We are developing our CellMist System as a promising new alternative for patients suffering from burns, chronic and acute wounds, and scars.
Home Page: www.renovacareinc.com
9375 East Shea Blvd
Scottsdale,
AZ
85260
United States
Phone:
888 398 0202
Officers
| Name | Title |
|---|---|
| Mr. Harmel S. Rayat | Pres, CEO, CFO, Interim Sec. & Chairman |
| Dr. Robin A. Robinson Ph.D. | Chairman of Scientific Advisory Board, VP & Chief Scientific Officer |
| Mr. Justin Frere CPA, CPA, M.B.A., MBA | Treasurer |
| Mr. Alan L. Rubino | Consultant |
| Dr. Jo Ellen Schweinle M.D. | Chief Medical Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.1083 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1 |